Large granular lymphocyte leukemia: natural history and response to treatment (Q43109504)

14 November 2017

title

Large granular lymphocyte leukemia: natural history and response to treatment (English)

1 reference

14 November 2017

1 reference

Fiona Quinn

5

0 references

Paul V. Browne

object named as

Paul Browne

9

0 references

Elisabeth Vandenberghe

object named as

Elisabeth Vandenberghe

12

0 references

author name string

Anne F Fortune

1

1 reference

14 November 2017

Kevin Kelly

2

1 reference

14 November 2017

Jeremy Sargent

3

1 reference

14 November 2017

David O'Brien

4

1 reference

14 November 2017

Nick Chadwick

6

1 reference

14 November 2017

Catherine Flynn

7

1 reference

14 November 2017

Eibhlin Conneally

8

1 reference

14 November 2017

Gerard M Crotty

10

1 reference

14 November 2017

Patrick Thornton

11

1 reference

14 November 2017

publication date

1 May 2010

1 reference

14 November 2017

1 reference

14 November 2017

volume

51

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

839-845

1 reference

Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Chronic lymphoproliterative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Current concepts: large granular lymphocyte leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Clinical features of large granular lymphocyte leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Survival signals in leukemic large granular lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Prototypical HTLV-I/II infection is rare in LGL leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

21 January 2018

LGL leukemia and HTLV.

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Large granular lymphocyte leukaemia occurring after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Congenital and acquired neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

The role of alemtuzumab in the management of T-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti‐CD52 monoclonal antibody alemtuzumab (Campath‐1H)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428191003706947

10.3109/10428191003706947

21 January 2018

Identifiers

DOI

1 reference

release_i5krdtzfxnbbbouv2mp2u2o2aa

14 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i5krdtzfxnbbbouv2mp2u2o2aa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference